Macrogenics: Q4 Earnings Insights

Comments
Loading...

Macrogenics MGNX reported its Q4 earnings results on Thursday, March 7, 2024 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Macrogenics missed estimated earnings by -400.0%, reporting an EPS of $-0.75 versus an estimate of $-0.15.

Revenue was down $62.38 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.38 which was followed by a 17.0% increase in the share price the next day.

Here's a look at Macrogenics's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.10 -0.52 0.45 0.10
EPS Actual 0.28 0.92 -0.61 0.21
Revenue Estimate 48.86M 29.74M 86.49M 58.78M
Revenue Actual 10.40M 13.14M 24.50M 73.10M

To track all earnings releases for Macrogenics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!